about
Proteins specifically hyperexpressed in a coeliac disease patient with aberrant T cells.MTHFR polymorphisms in gastric cancer and in first-degree relatives of patients with gastric cancer.Protein signature characterizing Helicobacter pylori strains of patients with autoimmune atrophic gastritis, duodenal ulcer and gastric cancerLatent membrane protein 1 deletion mutants accumulate in reed-sternberg cells of human immunodeficiency virus-related Hodgkin's lymphoma.Genetic diversity of the KIR/HLA system and susceptibility to hepatitis C virus-related diseases.High serum levels of soluble CD40-L in patients with undifferentiated nasopharyngeal carcinoma: pathogenic and clinical relevance.The frequency of CD127(+) hepatitis C virus (HCV)-specific T cells but not the expression of exhaustion markers predicts the outcome of acute HCV infection.Recent patents relating to HCV molecules like putative targets for therapeutic intervention.HCV-related liver and lymphoproliferative diseases: association with polymorphisms of IL28B and TLR2.Human immunodeficiency virus-associated precursor T-lymphoblastic leukemia/lymphoblastic lymphoma: report of a case and review of the literature.Genetic diversity of the KIR/HLA system and outcome of patients with metastatic colorectal cancer treated with chemotherapy.Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas.The versatile role of gliadin peptides in celiac disease.IGKV3 proteins as candidate "off-the-shelf" vaccines for kappa-light chain-restricted B-cell non-Hodgkin lymphomas.Impact of immunogenetic IL28B polymorphism on natural outcome of HCV infection.Genetic insights into the disease mechanisms of type II mixed cryoglobulinemia induced by hepatitis C virus.B-cell lymphomas associated with HCV infection.A new human leukocyte antigen class I allele: HLA-A*02:374.Improving detection of celiac disease patients: a prospective study in iron-deficient blood donors without anemia in north Italy.Identification and sequence analysis of a novel human leukocyte antigen allele B*51:141.Different rates of CD4+ and CD8+ T-cell proliferation in interleukin-2-treated human immunodeficiency virus-positive subjects.The effects of CD40 ligation on peripheral blood mononuclear cell interleukin-12 and interleukin-15 production and on monocyte CD14 surface antigen expression in human immunodeficiency virus-positive patients.Identification of new major histocompatibility complex-A, -B, -C alleles in chimpanzees (Pan troglodytes).HLA-G+3027 polymorphism is associated with tumor relapse in pediatric Hodgkin's lymphoma.Characterizing Metastatic HER2-Positive Gastric Cancer at the CDH1 Haplotype.A new mutation of the CDH1 gene in a patient with an aggressive signet-ring cell carcinoma of the stomach.Identification of four novel MHC-C alleles in chimpanzees.Use of Metabolomics as a Complementary Omic Approach to Implement Risk Criteria for First-Degree Relatives of Gastric Cancer Patients.Description of two new major histocompatibility complex (MHC) class II DRB1 [Pan troglodytes (Patr)-DRB1] alleles.Comment re: Ran-GTP control of tumor cell mitosis.Undifferentiated nasopharyngeal carcinoma from a nonendemic area: Protective role of HLA allele products presenting conserved EBV epitopesHCV-NS3 and IgG-Fc crossreactive IgM in patients with type II mixed cryoglobulinemia and B-cell clonal proliferationsKIR/HLA Combination Associated with the Risk of Complications in Celiac DiseaseClinical Significance of Polymorphisms in Immune Response Genes in Hepatitis C-Related Hepatocellular CarcinomaMorphological aspects of an experimental tumour photosensitized with a meso-substituted cationic porphyrinKinetics of lymphokine production in HIV+ patients treated with highly active antiretroviral therapy and interleukin 2KIR molecules: recent patents of interest for the diagnosis and treatment of several autoimmune diseases, chronic inflammation, and B-cell malignanciesPolymorphism in Toll-Like Receptors and Helicobacter Pylori Motility in Autoimmune Atrophic Gastritis and Gastric CancerComplete and Durable Response to Combined Chemo/Radiation Therapy in EGFR Wild-Type Lung Adenocarcinoma with Diffuse Brain Metastases
P50
Q33276657-47D2468E-C185-4AF9-8D68-2F2A6B2D9223Q33579778-4BFCD83B-D9AF-4192-9915-96F68C1B31E6Q33612957-E2BCBC61-E124-4E28-9CCD-F06AB3BDDD26Q33780975-79F9BD3E-B4B2-4D15-9890-E3E26942DB0CQ35107234-05296AC7-32C5-45E0-AC2F-E9EA8B3BC200Q35674802-CCEFDB48-5F09-40DA-9B9F-0347FEF6FC1BQ36760218-841226A2-BF18-4417-90F2-68053B387122Q37347951-E65AE1D6-B1A0-4F3F-8B3D-CAFAF95B9B3BQ37437190-E32F3408-5F37-421E-9836-9920E2C23BF1Q37475341-CD4ABC00-2799-47FB-B01F-70687976E313Q37537926-60750326-A793-44B1-88D6-AFA65749EF5AQ37867290-D342906E-3E4E-4977-B923-E02376493877Q38059073-DA17FF8E-7A2F-4094-80D4-CE395834A29FQ39329992-F30B7039-10DE-4D34-95B3-B8EE0A5FAE4DQ42133572-72E09CCB-169E-4A9C-808D-A760D52A0F1AQ42634416-B31E6B51-5D8F-4B2B-8B43-9C1DCDFA565DQ43036745-18A64451-93E7-4FEA-A2A7-22226CC9CA75Q43610563-2F86476A-BF6F-4324-9D31-E4BB64030EFAQ44755373-FE6E8A2F-7527-441A-B06C-4EFD3FA9A900Q44853272-56925E65-49A7-4B28-A81A-F0E7A57D04B5Q45735994-298721E1-6EEC-4E7D-9296-2A80D425F8F9Q45750402-BEE2A9E7-321E-46E0-A779-F5AFDCD0CAF8Q46792217-F8199F1B-6A24-4C76-8F81-A036A222C758Q47098973-340F8674-D636-4FED-95BE-E3E1F443180EQ47218550-E6BF3AB8-9B3E-4ADF-820A-00C629B23628Q47409192-B9A9C58C-89D9-431B-BEC5-4B190D857D68Q48078874-47682BC8-9C59-4FF4-ACDD-9B640180F9B1Q52666367-9148F3CE-3D72-4828-99E6-1780E4D011F3Q52839932-36ACE896-F79C-4003-8856-C71E52B6894FQ53419654-7A4FFE16-53F5-4C82-8B30-3F3B5FBF3035Q57056118-23AF65F3-2597-4708-9B2E-237FC7360C47Q58200842-A29C09CD-09F7-40BD-BA3D-718C5F28B956Q61601916-7BB4BC62-3B9C-4776-958C-7EB03CEA8B1EQ64086786-CC5A977B-A880-49F9-9212-5AF3567665A8Q72038170-C8B45806-3740-492F-AD5B-494CBA7F1687Q73117776-B8EFB4CC-F02D-457D-8029-427B2E958F88Q84591656-ECAC179F-3225-48CC-AA23-A58A0EB5B10EQ91981231-D6D1931D-538A-4CAB-B58F-1E2995A3A8F7Q93060450-FCDF0B38-152E-4074-9FC9-70F6CFAC2A2C
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Laura Caggiari
@ast
Laura Caggiari
@en
Laura Caggiari
@es
Laura Caggiari
@nl
type
label
Laura Caggiari
@ast
Laura Caggiari
@en
Laura Caggiari
@es
Laura Caggiari
@nl
prefLabel
Laura Caggiari
@ast
Laura Caggiari
@en
Laura Caggiari
@es
Laura Caggiari
@nl
P106
P1153
6603038417
P31
P496
0000-0003-1651-6653